Evidence map›Paper›PMID 33293634›Full record

ArticleScientific reports2020

Determinants of delay in diagnosis and end stage at presentation among breast cancer patients in Iran: a multi-center study.

Elahe Foroozani, Reza Ghiasvand, Mohammad Mohammadianpanah, Sima Afrashteh, Dariush Bastam, Fatemeh Kashefi, Saba Shakarami, Mostafa Dianatinasab

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 5 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 5 pooled it
2.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 5 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Elahe ForoozaniSchool of Physical and Occupational Therapy, McGill University, Montreal, Canada.
Reza GhiasvandOslo Centre for Biostatistics and Epidemiology, Oslo University Hospital, Oslo, Norway.
Mohammad MohammadianpanahColorectal Research Center, Faghihi Hospital, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.
Sima AfrashtehDepartment of Epidemiology, Faculty of Public Health, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran.
Dariush BastamDepartment of Epidemiology, Faculty of Public Health, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran. daryoush.bastam@yahoo.com.ORCID 0000-0001-9280-3094
Fatemeh KashefiDeputy of Health, Mazandaran University of Medical Sciences, Sari, Islamic Republic of Iran.
Saba ShakaramiDepartment of Epidemiology, Faculty of Public Health, Ilam University of Medical Sciences, Ilam, Islamic Republic of Iran.
Mostafa DianatinasabDepartment of Epidemiology, Faculty of Public Health, Shiraz University of Medical Sciences, Shiraz, Islamic Republic of Iran. m.dianatinasab@maastrichtuniversity.nl.ORCID 0000-0002-0185-5807
Shiraz University of Medical Sciences · IRMazandaran University of Medical Sciences · IRMcGill University · CAMedical University of Ilam · IROslo University Hospital · NO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the reasons for high mortality of breast cancer (BC) is long delay in seeking medical care and end stage at presentation. This study was designed to measure the association between a wide range of socio-demographic and clinical factors with diagnostic delay in BC and stage at presentation among Iranian patients. From June 2017 to December 2019, 725 patients with newly diagnosed BC in Shiraz and Kermanshah were selected and information on BC diagnosis delay was obtained from the patient's medical record. Data on socio-economic status was obtained via a structured interview. Our findings suggest that 45.8% of the patients were diagnosed at a late stage (stage 3 or higher). A total of 244 (34%) patients had more than 3 months delay in diagnosis. We found a significant association between stage at diagnosis and place of residence (adjusted odds ratio (aOR rural vs. urban = 1.69, 95% CI 1.49-1.97), marital status (aOR 1.61, 95% CI 1.42-1.88), family history of BC (aOR 1.46, 95% CI 1.01-2.13), and history of benign breast disease (BBD) (aOR 1.94, 95% CI 1.39-2.72) or unaware of breast self-examination (BSE) (aOR 1.42, 95% CI 1.42-1.85), delay time (aOR 3.25, 95% CI 1.04-5.21), and left breast tumor (aOR right vs. left 2.64, 95% CI 1.88-3.71) and smoking (aOR no vs. yes 1.59, 95% CI 1.36-1.97). Also, delay in diagnosis was associated with age, family income, health insurance, place of residence, marital status, menopausal status, history of BBD, awareness of breast self-examination, type of first symptoms, tumor histology type, BMI and comorbidity (p < 0.05 for all). Factors including history of BBD, awareness of BSE, and suffering from chronic diseases were factors associated with both delay in diagnosis and end stage of disease. These mainly modifiable factors are associated with the progression of the disease.

Indexed as

Delayed DiagnosisAdultBreastBreast NeoplasmsCross-Sectional StudiesFemaleHumansInsurance, HealthIranMarital StatusMiddle AgedRisk FactorsRural PopulationUrban Population

Identifiers

PMID33293634
PMCPMC7723040
OpenAlexW3113150183

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.